R-hyper-CVAD versus R-CHOP/cytarabine with high-dose therapy and autologous haematopoietic stem cell support in fit patients with mantle cell lymphoma: 20 years of single-center experience. [electronic resource]
Producer: 20180111Description: 277-287 p. digitalISSN:- 1432-0584
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Cytarabine -- administration & dosage
- Dexamethasone -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Female
- Hematopoietic Stem Cell Transplantation
- Hospitalization -- economics
- Humans
- Lymphoma, Mantle-Cell -- mortality
- Male
- Middle Aged
- Prednisone -- administration & dosage
- Quality of Life -- psychology
- Remission Induction
- Retrospective Studies
- Rituximab
- Survival Analysis
- Transplantation, Autologous
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.